RGO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Regeneron Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 601.1 EUR -1%

Market Cap: €66.2B

R	Regeneron Pharmaceuticals Inc F:RGO	US
A	Adaro Energy Indonesia TBK PT XMUN:A64	ID
C	Constellation Brands Inc XMUN:CB1A	US
B	Brown & Brown Inc XBER:BTW	US
C	Compagnie de Saint Gobain SA SWB:GOB	FR
H	Helen of Troy Ltd F:HT2	BM
	Swatch Group AG OTC:SWGAF	CH
	SmileDirectClub Inc OTC:SDCCQ	US
	Traction Uranium Corp OTC:TRCTD	CA
	Leafly Holdings Inc NASDAQ:LFLY	US

Profitability Summary

Regeneron Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

87%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

89% > 87%

Healthy Operating Margin

27%

Strong 3Y Average Operating Margin

32%

Declining Operating Margin

40% > 27%

Exceptional Net Margin

31%

Strong 3Y Average Net Margin

32%

Declining Net Margin

34% > 31%

Exceptional Free Cash Flow Margin

26%

Strong 3Y Average Free Cash Flow Margin

26%

Free Cash Flow Margin is Increasing

20% > 26%

Positive ROE

15%

Positive 3Y Average ROE

Positive 3Y Average ROIC

17%

Declining ROIC

22% > 18%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.